MedPath

HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

Not Applicable
Completed
Conditions
Fibromyalgia
Chronic Pain Syndrome
Interventions
Behavioral: Psychotherapy
Biological: HBOT
Registration Number
NCT03376269
Lead Sponsor
Assaf-Harofeh Medical Center
Brief Summary

The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on 2 types of patients' population suffering from chronic pain syndrome (Fibromyalgia): patients with history of psychological trauma and patients with history of traumatic brain injury.

Detailed Description

This study is a prospective clinical trial. After signing a written informed consent, all patients will be invited to medical evaluation including pain sensitivity examination and a series of questionnaires. In addition, all patients will have chest X-ray, cognitive evaluation, brain MRI and brain Single-photon emission computed tomography (SPECT)

. A second brain MRI, brain SPECT, pain sensitivity evaluation and questionnaires will be done after 3 months of treatment (60 sessions of HBOT). The HBOT procedure will be performed at the Sagol center for hyperbaric medicine and research of Assaf Harofeh Medical Center, Israel.

The following HBOT protocol will be applied for all patients: 12 weeks, 5 times per week, daily administration of 100% O2 for 90 minutes at a pressure of 2 absolute atmospheres (ATA) including 5 minutes air breaks every 30 minutes.

Patients with history of psychological trauma are also being treated with creative art psychotherapy. These patients will be randomly assigned to one of the two groups: (1) single intervention with creative art psychotherapy (psychotherapy group); (2) combined concurrent intervention of HBOT and creative art psychotherapy. Groups 1 will serve as controls during the first 3 months and then will be crossed to get HBOT. Before the cross to the HBOT they will have 2nd full evaluation (questioners and brain imaging).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Females
  • Age over 18
  • Known fibromyalgia (chronic pain syndrome) for more than 1 year
Exclusion Criteria
  • Any past hyperbaric treatment prior to inclusion
  • Patients with chest x-ray pathology incompatible with hyperbaric environment
  • Patients with middle ear problems
  • Patients, who cannot "pump", equals middle ear pressure, effectively
  • Patients who suffer from claustrophobia
  • Inability or Refusing to sign the Informed Consent Form

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
psychotherapyPsychotherapysingle intervention with creative art psychotherapy
Combined HBOT/psychotherapyHBOTcombined concurrent intervention of HBOT and creative art psychotherapy.
Combined HBOT/psychotherapyPsychotherapycombined concurrent intervention of HBOT and creative art psychotherapy.
Primary Outcome Measures
NameTimeMethod
Pain sensitivityChange After 3 months

Using (AlogMed) dolorimeter, pain sensitivity will be examined in 18 trigger points (scale0-18)

Brain microstructureChange after 3 months

MRI dynamic tensor imaging sequence will be performed (DTI). Fractional anisotropy (FA) values will be assessed at base line and at 3 months. The changes at 3 months from baseline will be compared

Brain MetabolismChange after 3 months

Brain metabolism will be assessed using SPECT at baseline, 3 monthsThe counts for each different Broadmann area values will be calculated. The changes at 3 months from baseline will be compared.

Secondary Outcome Measures
NameTimeMethod
Sensory symptomsChange after 3 months

Sensory symptoms will be evaluated using the Sensory Profile questionnaires .

Psychological symptomsChange after 3 months

Psychological symptoms will be evaluated using Brief Symptom Inventory(BSI) questionnaire.(scale 0-20)

Fibromyalgia Impact on quality of lifeChange after 3 months

Evaluated by Fibromyalgia Impact Questionnaire (FIQ).(scale 0-100)

Somatoform Dissociation Questionnaire (SDQ-20)Change after 3 months

Dissociation symptoms will be evaluated using the Somatoform Dissociation Questionnaire (SDQ-20).

Childhood trauma psychological effectsChange after 3 months

Childhood trauma psychological effects will be evaluated using the Childhood Trauma Questionnaire (CTQ) questionnaires.(scale 0-125)

StressChange after 3 months t

Stress will be evaluated using the Perceived stress scale (PSS) questionnaire.(scale 0-51)

Short form health survey (sf-36)Change after 3 months

Quality of live will be evaluated by Quality of Life RAND Short form 36 questionnaire (SF36).(scale 0-100) higher score means better outcome.

Trial Locations

Locations (1)

Assaf-Harofeh Medical Center

🇮🇱

Zerifin, Israel

© Copyright 2025. All Rights Reserved by MedPath